Research Spacer image for layout

Clinical Research

Higgs P, Janda M, Asher R, ..., Obermair A. Pelvic floor functional outcomes after total abdominal vs total laparoscopic hysterectomy for endometrial cancer. Am J Obstet Gynecol. 2018 218(4):419.

Janda M, Armfield NR, Kerr G, ..., Obermair A. Surgical approach to hysterectomy and barriers to using minimally invasive methods. Aust N Z J Obstet Gynaecol. 2018 May 15.

Nagle CM, O'Mara TA, Tan Y, ..., Obermair A, et al. Endometrial cancer risk and survival by tumor MMR status. J Gynecol Oncol. 2018 29(3):e39.

Obermair A, Janda M, Gebski V. All-cause death in young women with endometrial cancer who receive progesterone therapy. Am J Obstet Gynecol. 2018 Mar 9.

Celentano V, Smart N, McGrath J, ..., Obermair A, et al. LAP-VEGaS Practice Guidelines for Reporting of Educational Videos in Laparoscopic Surgery: A Joint Trainers and Trainees Consensus Statement. Ann Surg. 2018 Mar 5.

Smith D, Stewart CJR, Clarke EM, ..., Obermair A, et al. ER and PR expression and survival after endometrial cancer. Gynecol Oncol. 2018 Feb;148(2):258-266.

Hayes SC, Janda M, Ward LC, ..., Obermair A. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors. Gynecol Oncol. 2017;146(3):623-629.

Obermair A, Simunovic M, Isenring L, et al. Nutrition interventions in patients with gynecological cancers requiring surgery. Gynecol Oncol. 2017 Apr;145(1):192-199.

Janda M, Gebski V, Davies LC, ...., Obermair A. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial. JAMA. 2017 Mar 28;317(12):1224-1233.

Obermair A, Brennan DJ, Baxter E, Armes JE, Gebski V, Janda M. Surgical safety and personal costs in morbidly obese, multimorbid patients diagnosed with early-stage endometrial cancer having a hysterectomy. Gynecol Oncol Res Pract. 2016 Feb 9;3:1.

Obermair A, Youlden D, Baade P, Janda M. Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study. Asia Pac J Clin Oncol. 2016 May 27. 

Baker J, Janda M, Graves N, Bauer J, Banks M, Garrett A, Chetty N, Crandon AJ, Land R, Nascimento M, Nicklin JL, Perrin LC, Obermair A. Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial. Gynecol Oncol. 2015;137(3):516-22. 

Brennan DJ, Hackethal A, Mann KP, Mutz-Dehbalaie I, Fiegl H, Marth C, Obermair ASerum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance. BMC Cancer. 2015;15:33.

Tan YY, Spurdle AB, Obermair A. Knowledge, attitudes and referral patterns of lynch syndrome: a survey of clinicians in Australia. J Pers Med. 2014;4(2):218-44. 

Hackethal ABrennan DRao ALand RObermair A et al. Consideration for safe and effective gynaecological laparoscopy in the obese patient. Arch Gynecol Obstet. 2015;292(1):135-41

Beesley VL, Rowlands IJ, Hayes SC, Janda M, O'Rourke P, Marquart L, Quinn MA, Spurdle AB, Obermair A, Brand A, Oehler MK, Leung Y, McQuire L, Webb PM; Australian National Endometrial Cancer Study Group. Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer. Gynecol Oncol. 2015;136(1):87-93. 

Anuradha S, Webb PM, Blomfield P, Brand AH, Friedlander M, Leung Y, Obermair A, Oehler MK, Quinn M, Steer C, Jordan SJ. Survival of Australian women with invasive epithelial ovarian cancer: a population-based study. Med J Aust. 2014 Sep 1;201(5):283-8. 

Hawkes AL, Quinn M, Gebski V, Armes J, Brennan D, Janda M; feMME Trial Committee, Obermair A. Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial. Contemp Clin Trials. 2014;39(1):14-21. 

Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K, Arnold ST, Thompson BA, Lose FA, Parsons MT, Walters RJ, Pearson SA, Cummings M, Oehler  MK, Blomfield PB, Quinn MA, Kirk JA, Stewart CJ, Obermair A, et al. Moline et al. J Clin Oncol. 2014;32(21):2278-9. 

Rowlands IJ, Beesley VL, Janda M, Hayes SC, Obermair A, Quinn MA, Brand A, Leung Y, McQuire L, Webb PM; Australian National Endometrial Cancer Study Group.  Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancer. Gynecol Oncol. 2014;133(2):314-8.

Obermair A. Comment on 'External multicentre validation of a nomogram predicting the risk of relapse in patients with borderline ovarian tumours'. Br J Cancer. 2014;111(12):2375. 

Varughese E, Janda M, Obermair A. Can the use of quality assurance tools reduce the impact of surgical complications on the well-being of obstetricians and gynaecologists in Australia and New Zealand? Aust N Z J Obstet Gynaecol. 2014 Feb;54(1):30-5.

Buchanan DD, Tan YY, Walsh MD, Clendenning M, Metcalf AM, Ferguson K, Arnold ST, Thompson BA, Lose FA, Parsons MT, Walters RJ, Pearson SA, Cummings M, Oehler MK, Blomfield PB, Quinn MA, Kirk JA, Stewart CJ, Obermair A, et al. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. J Clin Oncol. 2014 Jan 10;32(2):90-100. 

Brennan DJ, Hackethal A, Metcalf AM, Coward J, Ferguson K, Oehler MK, Quinn MA, Janda M, Leung Y, Freemantle M; ANECS Group, Webb PM, Spurdle AB, Obermair A. Serum HE4 as a prognostic marker in endometrial cancer--a population based study. Gynecol Oncol. 2014 Jan;132(1):159-65. 

Obermair A, Youlden DR, Baade PD, Janda M. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study. Int J Cancer. 2014;134(9):2211-22. 

Dong Y, Loessner D, Irving-Rodgers H, Obermair A, Nicklin JL, Clements JA. Metastasis of ovarian cancer is mediated by kallikrein related peptidases. Clin Exp Metastasis. 2014;31(1):135-47. 

Belavy D, Janda M, Baker J, Obermair A. Epidural analgesia is associated with an increased incidence of postoperative complications in patients requiring an abdominal hysterectomy for early stage endometrial cancer. Gynecol Oncol. 2013;131(2):423-9. 

Obermair A, Janda M, Gebski V. Identification of doctors at risk of recurrent complaints: a national study of healthcare complaints in Australia. BMJ Qual Saf. 2013 Oct;22(10):878.

Baker J, Janda M, Belavy D, Obermair A. Differences in Epidural and Analgesic Use in Patients with Apparent Stage I Endometrial Cancer Treated by Open versus Laparoscopic Surgery: Results from the Randomised LACE Trial. Minim Invasive Surg. 2013;2013:764329.

1: Wills A, Obermair A. A review of complications associated with the surgical
treatment of vulvar cancer. Gynecol Oncol. 2013 Jul 14. doi:pii:
S0090-8258(13)00997-9. 10.1016/j.ygyno.2013.07.082. [Epub ahead of print] PubMed 
PMID: 23863358.
2: Hackethal A, Brennan DJ, Land R, Nascimento M, Nicklin J, Obermair A.
Feasibility and outcomes of ureteroureterostomy and extravesical
ureteroneocystostomy as part of radical surgery for infiltrating gynecologic
disease. Int J Gynecol Cancer. 2013 Jul;23(6):1139-45. doi:
10.1097/IGC.0b013e3182993790. PubMed PMID: 23792608.
3: Fung JN, Jeffery PL, Lee JD, Seim I, Roche D, Obermair A, Chopin LK, Chen C.
Silencing of ghrelin receptor expression inhibits endometrial cancer cell growth 
in vitro and in vivo. Am J Physiol Endocrinol Metab. 2013 Jul;305(2):E305-13.
doi: 10.1152/ajpendo.00156.2013. Epub 2013 Jun 4. PubMed PMID: 23736537.
4: Kondalsamy-Chennakesavan S, Obermair A. Differentiating stage I epithelial
ovarian cancer from benign disease in women with adnexal tumours using biomarkers
or the ROMA algorithm. Gynecol Oncol. 2013 Aug;130(2):400. doi:
10.1016/j.ygyno.2013.04.471. Epub 2013 May 6. PubMed PMID: 23660370.
5: Graves N, Janda M, Merollini K, Gebski V, Obermair A; LACE trial committee.
The cost-effectiveness of total laparoscopic hysterectomy compared to total
abdominal hysterectomy for the treatment of early stage endometrial cancer. BMJ
Open. 2013 Apr 18;3(4). doi:pii: e001884. 10.1136/bmjopen-2012-001884. Print
2013. PubMed PMID: 23604345; PubMed Central PMCID: PMC3641468.
6: Nagle CM, Marquart L, Bain CJ, O'Brien S, Lahmann PH, Quinn M, Oehler MK,
Obermair A, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study
Group. Impact of weight change and weight cycling on risk of different subtypes
of endometrial cancer. Eur J Cancer. 2013 Aug;49(12):2717-26. doi:
10.1016/j.ejca.2013.03.015. Epub 2013 Apr 11. PubMed PMID: 23583438.
7: Kondalsamy-Chennakesavan S, Hackethal A, Bowtell D; Australian Ovarian Cancer 
Study Group, Obermair A. Differentiating stage 1 epithelial ovarian cancer from
benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA 
and patient's age. Gynecol Oncol. 2013 Jun;129(3):467-71. doi:
10.1016/j.ygyno.2013.03.001. Epub 2013 Mar 13. PubMed PMID: 23500084.
8: Jordan S, Steer C, DeFazio A, Quinn M, Obermair A, Friedlander M, Francis J,
O'Brien S, Goss G, Wyld D, Australian Ovarian Cancer Study Group, Webb P; Ovarian
Cancer Patterns of Care Study Group. Patterns of chemotherapy treatment for women
with invasive epithelial ovarian cancer--a population-based study. Gynecol Oncol.
2013 May;129(2):310-7. doi: 10.1016/j.ygyno.2013.02.007. Epub 2013 Feb 9. PubMed 
PMID: 23403164.
9: Obermair A, Tang A, Kondalsamy-Chennakesavan S, Ngan H, Zusterzeel P, Quinn M,
Carter J, Leung Y, Janda M. Nomogram to predict the probability of relapse in
patients diagnosed with borderline ovarian tumors. Int J Gynecol Cancer. 2013
Feb;23(2):264-7. doi: 10.1097/IGC.0b013e31827b8844. PubMed PMID: 23295940.
10: Russell P, Lynnhtun K, James D, Obermair A. Endometrial polyp and
endometriosis with atypical stromal cells. Pathology. 2013 Feb;45(2):191-3. doi: 
10.1097/PAT.0b013e32835c87b6. PubMed PMID: 23250045.
11: Rowlands IJ, Lee C, Janda M, Nagle CM, Obermair A, Webb PM; Australian
National Endometrial Cancer Study Group. Predicting positive and negative impacts
of cancer among long-term endometrial cancer survivors. Psychooncology. 2012 Dec 
12. doi: 10.1002/pon.3236. [Epub ahead of print] PubMed PMID: 23239462.
12: Tan YY, McGaughran J, Ferguson K, Walsh MD, Buchanan DD, Young JP, Webb PM,
Obermair A, Spurdle AB; ANECS Group. Improving identification of lynch syndrome
patients: a comparison of research data with clinical records. Int J Cancer. 2013
Jun 15;132(12):2876-83. doi: 10.1002/ijc.27978. Epub 2013 Jan 11. PubMed PMID:
23225370.

Wills A, Obermair A. A review of complications associated with the surgical treatment of vulvar cancer. Gynecol Oncol. 2013;131(2):467-479.

Hackethal A, Brennan DJ, Land R, Nascimento M, Nicklin J, Obermair A. Feasibility and outcomes of ureteroureterostomy and extravesical ureteroneocystostomy as part of radical surgery for infiltrating gynecologic disease. Int J Gynecol Cancer. 2013;23(6):1139-45.

Fung JN, Jeffery PL, Lee JD, Seim I, Roche D, Obermair A, Chopin LK, Chen C. Silencing of ghrelin receptor expression inhibits endometrial cancer cell growth in vitro and in vivo. Am J Physiol Endocrinol Metab. 2013;305(2):E305-13.

Kondalsamy-Chennakesavan S, Obermair A. Differentiating stage I epithelial ovarian cancer from benign disease in women with adnexal tumours using biomarkers or the ROMA algorithm. Gynecol Oncol. 2013 Aug;130(2):400.

Graves N, Janda M, Merollini K, Gebski V, Obermair A; LACE trial committee. The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer. BMJ Open. 201318;3(4).

Nagle CM, Marquart L, Bain CJ, O'Brien S, Lahmann PH, Quinn M, Oehler MK, Obermair A, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study Group. Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer. Eur J Cancer. 2013;49(12):2717-26.

Kondalsamy-Chennakesavan S, Hackethal A, Bowtell D; Australian Ovarian Cancer  Study Group, Obermair A. Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age. Gynecol Oncol. 2013;129(3):467-71.

Jordan S, Steer C, DeFazio A, Quinn M, Obermair A, et al. Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study. Gynecol Oncol. 2013;129(2):310-7.

Obermair A, Tang A, Kondalsamy-Chennakesavan S, Ngan H, Zusterzeel P, Quinn M, Carter J, Leung Y, Janda M. Nomogram to predict the probability of relapse in patients diagnosed with borderline ovarian tumors. Int J Gynecol Cancer. 2013;23(2):264-7.

Russell P, Lynnhtun K, James D, Obermair A. Endometrial polyp and endometriosis with atypical stromal cells. Pathology. 2013;45(2):191-3.

Rowlands IJ, Lee C, Janda M, Nagle CM, Obermair A, et al. Predicting positive and negative impacts of cancer among long-term endometrial cancer survivors. Psychooncology. 2013;22(9):1963-71. 

Tan YY, McGaughran J, Ferguson K, Walsh MD, Buchanan DD, Young JP, Webb PM, Obermair A, Spurdle AB; ANECS Group. Improving identification of lynch syndrome patients: a comparison of research data with clinical records. Int J Cancer. 2013;132(12):2876-83. 

Neill AS, Nagle CM, Protani MM, Obermair A, Spurdle AB, Webb PM; for the Australian National Endometrial Cancer Study Group. Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: A case-control study, systematic review and meta-analysis. Int J Cancer. 2013;132(5):1146-55.

Obermair A, Janda M, Baker J, et al. Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: results from a randomised controlled trial. Eur J Cancer. 2012;48(8):1147-53. 

Kondalsamy-Chennakesavan S, ..., Obermair A. Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial. Eur J Cancer. 2012;48(14):2155-62. 

Varughese E, Kondalsamy-Chennakesavan S, Obermair A. The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: a retrospective study. J Ovarian Res. 2012;22;5:11. 

Tang A, Kondalsamy-Chennakesavan S, Ngan H, Zusterzeel P, Quinn M, Carter J, Leung Y, Obermair A. Prognostic value of elevated preoperative serum CA125 in ovarian tumors of low malignant potential: A multinational collaborative study (ANZGOG0801). Gynecol Oncol. 2012;126(1):36-40.

Tan J, Chetty N, Kondalsamy-Chennakesavan S, Crandon A, Garrett A, Land R, Nascimento M, Nicklin J, Perrin L, Obermair A. Validation of the FIGO 2009 staging system for carcinoma of the vulva. Int J Gynecol Cancer. 2012;22(3):498-502.

Kondalsamy-Chennakesavan S, Yu C, Kattan MW, Leung Y, Sykes P, Nascimento M, Nicklin J, Perrin L, Crandon A, Chetty N, Land R, Garrett A, Obermair A. Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer. Gynecol Oncol. 2012;125(3):520-5.

Baker J, Obermair A, Gebski V, Janda M. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with  atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature. Gynecol Oncol. 2012;125(1):263-70. 

Rowlands IJ, Nagle CM, Spurdle AB, Webb PM; Australian National Endometrial Cancer Study Group; Australian Ovarian Cancer Study Group. Gynecological conditions and the risk of endometrial cancer. Gynecol Oncol. 2011;123(3):537-41. 

Nicklin J, Janda M, Gebski V, Jobling T, Land R, Manolitsas T, McCartney A, Nascimento M, Perrin L, Baker JF, Obermair A; for the LACE Trial Investigators. The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer. Int J Cancer. 2012;131(4):885-890.

Newton MJ, Hayes SC, Janda M, Webb PM, Obermair A, Eakin EG, Wyld D, Gordon LG, Beesley VL. Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study. BMC Cancer. 2011;11:389. 

Rowlands IJ, Weinstein P, Nagle CM, Spurdle AB, Webb PM; Australian National  Endometrial Cancer Study (ANECS); Australian Ovarian Cancer Study (AOCS). Season  of birth and risk of endometrial cancer. Asian Pac J Cancer Prev. 2011;12(5):1193-6.

Finnane A, Hayes SC, Obermair A, Janda M. Quality of life of women with lower-limb lymphedema following gynecological cancer. Expert Rev Pharmacoecon Outcomes Res. 2011;11(3):287-97. 

Kondalsamy-Chennakesavan S, van Vugt S, Sanday K, Nicklin J, Land R, Perrin L, Crandon A, Obermair A. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer. Int J Gynecol Cancer. 2010;20(7):1217-21. 

Harter P, Sehouli J, Reuss A, Hasenburg A, Scambia G, Cibula D, Mahner S, Vergote I, Reinthaller A, Burges A, Hanker L, Pölcher M, Kurzeder C, Canzler U, Petry KU, Obermair A, Petru E, Schmalfeldt B, Lorusso D, du Bois A. Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO. Int J Gynecol Cancer. 2011;21(2):289-95.

Kondalsamy-Chennakesavan S, Gordon LG, Sanday K, Bouman C, De Jong S, Nicklin J, Land R, Obermair A. Hospital costs associated with adverse events in gynecological oncology. Gynecol Oncol. 2011;121(1):70-5. 

Obermair A, et al. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma. Gynecol Oncol. 2011;120(2):179-84. 

Fearnley EJ, Marquart L, Spurdle AB, Weinstein P, Webb PM; Australian Ovarian Cancer Study Group and Australian National Endometrial Cancer Study Group. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study. Cancer Causes Control. 2010;21(12):2303-8. 

Janda M, Gebski V, Brand A, Hogg R, Jobling TW, Land R, Manolitsas T, McCartney A, Nascimento M, Neesham D, Nicklin JL, Oehler MK, Otton G, Perrin L, Salfinger S, Hammond I, Leung Y, Walsh T, Sykes P, Ngan H, Garrett A, Laney M, Ng TY, Tam K, Chan K, Wrede CD, Pather S, Simcock B, Farrell R, Obermair A. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial. Lancet Oncol. 2010; 11(8):772-80.

Obermair A, Youlden DR, Young JP, Lindor NM, Baron JA, Newcomb P, Parry S, Hopper JL, Haile R, Jenkins MA. Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer. 2010;127 11):2678-84.

Laky B, Janda M, Kondalsamy-Chennakesavan S, Cleghorn G, Obermair A. Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study. BMC Cancer. 2010;10:232.

Gordon LG, Obermair A. Potential hospital cost-savings attributed to improvements in outcomes for colorectal cancer surgery following self-audit. BMC Surg. 2010;10:4.

Bisseling KC, Kondalsamy-Chennakesavan S, Bekkers RL, Janda M, Obermair A. Depression, anxiety and body image after treatment for invasive stage one epithelial ovarian cancer. Aust N Z J Obstet Gynaecol. 2009;49(6):660-6.

Kondalsamy-Chennakesavan S, Bouman C, De Jong S, Sanday K, Nicklin J, Land R, Obermair A. Clinical audit in gynecological cancer surgery: development of a risk scoring system to predict adverse events. Gynecol Oncol. 2009 ;115(3):329-33.

Crandon AJ, Obermair A. Advanced cytoreductive surgery: Asia Pacific perspective. Gynecol Oncol. 2009 Aug;114(2 Suppl):S15-21.

Levenback CF, van der Zee AG, Rob L, Plante M, Covens A, Schneider A, Coleman R, Solima E, Hertel H, Barranger E, Obermair A, Roy M. Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol Oncol. 2009;114(2):151-6.

Obermair A, Tang A, Charters D, Weaver E, Hammond I. Survey of surgical skills of RANZCOG trainees. Aust N Z J Obstet Gynaecol. 2009;49(1):84-92.

Nicklin J, Perrin L, Crandon A, Land R, Nascimento M, Obermair A. Re: Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol. 2008;48(4):447.

Walsh MD, Young J, Spurdle A, Obermair A. Lynch syndrome in women less than 50 years of age with endometrial cancer. Obstet Gynecol. 2008;112(4):943.

Obermair A, Cheuk R, Pak SC, Perrin L, Nicklin J, Crandon A, Land R, Chennakes SK, Janda M, Tripcony L. Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma. Gynecol Oncol. 2008;110(3):280-5.

Obermair A, Gebski V, Frumovitz M, Soliman PT, Schmeler KM, Levenback C, Ramirez PT. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008 Sep-Oct;15(5):584-8.

Laky B, Janda M, Cleghorn G, Obermair A. Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr. 2008;87(6):1678-85.

Walsh MD, Cummings MC, Buchanan DD, Dambacher WM, Arnold S, McKeone D, Byrnes R, Barker MA, Leggett BA, Gattas M, Jass JR, Spurdle AB, Young J, Obermair A. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Clin Cancer Res. 2008 Mar 15;14(6):1692-700. 

Spurdle A, Webb P; Australian National Endometrial Cancer Study. Re: Excess of early onset multiple myeloma in endometrial cancer probands and their relatives suggests common susceptibility. Gynecol Oncol. 2008;109(1):153.

Pak SC, Martens M, Bekkers R, Crandon AJ, Land R, Nicklin JL, Perrin LC, Obermair A. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix. Aust N Z J Obstet Gynaecol. 2007;47(6):504-7.

Obermair A, Hiebl S. Laparoscopy in the treatment of ovarian tumours of low malignant potential. Aust N Z J Obstet Gynaecol. 2007;47(6):438-44.

Janda M, Youlden DR, Baade PD, Jackson D, Obermair A. Elderly patients with stage III or IV ovarian cancer: should they receive standard care? Int J Gynecol Cancer. 2008 Sep-Oct;18(5):896-907. 

Obermair A. Preoperative serum CA125 in surgical stage 1 epithelial ovarian cancer. Gynecol Oncol. 2007;107(2):357-8. 

Smith CJ, Heeren M, Nicklin JL, Perrin LC, Land R, Crandon AJ, Obermair A. Efficacy of routine follow-up in patients with recurrent uterine cancer. Gynecol Oncol. 2007;107(1):124-9. 

Obermair A, Crandon A, Perrin L, Walsh T, Carraro M, Nicklin J. Randomized Trial of skin closure after laparotomy for gynaecological surgery. Aust NZ J Surg. 2007;77:460-463.

Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lymphedema after gynecological cancer treatment : prevalence, correlates, and supportive care needs. Cancer 2007;109:2607-2614.

Garrett AJ, Nascimento MC, Nicklin JL, Perrin LC, Obermair A. Total laparoscopic hysterectomy: the Brisbane learning curve. Aust NZ J Obstet Gynaecol. 2007;47:65-9.

Obermair A, Fuller A, Lopez-Varela E, van Gorp T, Vergote I, Eaton L, Fowler J, Quinn M, Hammond I, Marsden D, Proietto A, Carter J, Davy M, Tripcony L, Abu-Rustum N. A new prognostic model for FIGO stage 1 epithelial ovarian cancer. Gynecol Oncol. 2007;104:607-11.

Laky B, Janda M, Bauer J, Vavra C, Cleghorn G, Obermair A. Malnutrition among gynaecological cancer patients. Eur J Clin Nutr. 2007;61:642-6.

Janda M, Gebski V, Forder P, Jackson D, Williams G, Obermair A; LACE Trial Committee. Total laparoscopic versus open surgery for stage 1 endometrial cancer: the LACE randomized controlled trial. Contemp Clin Trials. 2006;27:353-63.

Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ. Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer. Int J Gynecol Cancer 2005;15:319-24.

Janda M, Obermair A, Cella D, Perrin LC, Nicklin JL, Ward BG, Crandon AJ, Trimmel M. The functional assessment of cancer-vulvar: reliability and validity. Gynecol Oncol. 2005;97:568-75.

Paramasivam S, Tripcony L, Crandon A, Quinn M, Hammond I, Marsden D, Proietto A, Davy M, Carter J, Nicklin J, Perrin L, Obermair A. Prognostic importance of preoperative CA-125 in International Federation of Gynecology and Obstetrics stage I epithelial ovarian cancer: an Australian multicenter study.J Clin Oncol. 2005;23:5938-42.

Neppe C, Land R, Obermair A. Wrigley forceps to deliver a bulky uterus following a total laparoscopic hysterectomy for endometrial cancer. Aust N Z J Obstet Gynaecol. 2005;45:444-5.

Carraro Nascimento M, Diane Cominos, Davies TNJ, Obermair A. Vulval Keratoacanthoma: A Case Report. Gynecol Oncol 2005;97:674-6.

Carraro Nascimento M, Kelley A, Martitsch C, Weidner I, Obermair A. Postoperative analgesic requirements – Total Laparoscopic Hysterectomy vs. Vaginal Hysterectomy. Aust NZ J Obstet Gynaecol 2005;45-140-3.

Lataifeh I, Nascimento MC, Nicklin JL, Perrin LC, Crandon AJ, Obermair A. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol Oncol 2004;95:701-5.

Janda M, Obermair A, Cella D, Crandon AJ, Trimmel M. Vulvar cancer patients' quality of life: a qualitative assessment. Int J Gynecol Cancer 2004;14:875-81.

Janda M, Newman B, Obermair A, Woelfl H, Trimmel M, Schroeckmayr H, Widder J, Poetter R: Impaired quality of life in patients commencing radiotherapy for cancer. Strahlenther Onkol 2004;180:78-83.

Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ. Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol Oncol 2004;92:789-93.

McCartney AJ, Obermair A.: Total laparoscopic hysterectomy with a transvaginal tube. J Am Assoc Gynecol Laparosc 2004;11:79-82.

Petru E, Pasterk C, Reich O, Obermair A, Winter R, Breitenecker G. Small-cell carcinoma of the uterus and the vagina: experience with ten patients. Arch Gynecol Obstet 2004

Hammond IG, Obermair A, Taylor JD, Lawrence-Brown M. The overlay autogenous tissue (OAT) patch to control major intraoperative vascular injury in an ovine model. Gynecol Oncol 2004;94:560-3.

Hammond IG, Obermair A, Taylor JD, Lawrence-Brown M. The control of severe intraoperative bleeding using an overlay autogenous tissue (OAT) patch: case reports. Gynecol Oncol 2004;94:564-6.

Janda M, Obermair A, Cella D, Crandon AJ, Trimmel M. Vulvar cancer patients' quality of life: a qualitative assessment. Int J Gynecol Cancer 2004;14:875-81.

Dittrich Ch, Sevelda P, Salzer H, Obermair A, et al. Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin. Eur J Cancer. 2003;39:1129-40.

Denison U, Baumann J, Peters-Engl C, Samonigg H, Krippl P, Lang A, Obermair A, Wagner H, Sevelda P. Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 2003;79:347-53.

Nather A, Mayerhofer K, Grimm C, Hefler L, Leodolter S, Obermair A, Joura EA. Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy. Anticancer Res 2003;23:2991-4.

Obermair A, Ginbey P, McCartney AJ. Feasibility and safety of total laparoscopic radical hysterectomy. J Am Assoc Gynecol Laparosc 2003;10:345-9.

Preyer O, Obermair A, Formann E, Schmid W, Perrin LC, Ward BG, Crandon AJ, Nicklin J. The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. Gynecol Oncol 2002;86:269-73.

Obermair A, Cheuk R, Horwood K, Neudorfer M, Janda M, Nicklin JL, Perrin LC, Crandon AC. Anaemia before and during Concurrent Chemo-Radiotherapy in Patients with Cervical Carcinoma: Effect on Progression-Free Survival. Int J Gynecol Cancer 2003;13:633-9.

Preyer O, Obermair A, et al. The impact of positive peritoneal washings and serosal and adnexal involvement on survival in patients with stage IIIA uterine cancer. Gynecol Oncol. 2002;86:269-273.

Clayton RD, Obermair A, Hammond IG, Leung Y, McCartney AJ. The Western Australian experience of the use of en bloc resection of ovarian cancer with concomitant rectosigmoid colectomy. Gynecol Oncol 2002; 84: 53-57.

Nicklin JL, Perrin LC, Obermair A, McConachie, A, Cominos D. The significance of psammoma bodies on Nicklin JL, Perrin LC, Obermair A, McConachie I, Cominos D: The significance of cervical cytology smears. Gynecol Oncol 2001; 83: 6-9.

Obermair A, et al. Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecol Oncol 2001; 83:115-120.

Obermair A, et al. Impact of Hemoglobin Levels before and during Chemo-Radiotherapy on the Response to Treatment in Patients with Cervical Carcinoma: Preliminary Results. Cancer 2001; 92: 903-908.

Umek W, Obermair A, Stutterecker D, Hausler G, Leodolter S, Hanzal E: Three-dimensional ultrasound of the fermal urethra: comparing transvaginal and transrectal scanning. Ultrasound in Obstet Gynecol 2001; 17: 425-430.

Bodner K, Bodner-Adler B, Obermair A, Windbichler G, Petru E, Mayerhofer S, Czerwenka K, Leodolter S, Kainz C, Mayerhofer K: Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 2001; 81: 160-165.

Obermair A, et al. Primary Bartholin gland carcinoma: a report of seven cases. Aust N Z J Obstet Gynaecol 2001; 41: 78-81

Obermair A, et al. Primary fallopian tube cancer: the Queensland experience. Int J Gynaecol Cancer 2001; 11: 69-72.

Obermair A, et al. Peritoneal cytology: impact on disease-free survival in clincal stage I endometrioid adenocarcinoma of the uterus. Cancer Lett 2001; 164: 105-110.

Obermair A, Sevelda P. Impact of secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients. Acta Obstet Gynecol Scand 2001; 80: 432-436

Janda M, Gerstner N, Obermair A, Fuerst A, Wachter S, Dieckmann K, Ptter R. Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer 2000; 89: 1322-1328.

Janda M, Obermair A, Haidinger G, Waldhoer T, Vutuc C. Attitude and knowledge of Austrian women towards breast self examination. J Cancer Edu 2000; 15: 91-4.

Obermair A, et al. Impact of hysteroscopy on the diseaese-free survival in clinically stage I endometrial cancer patients. Int J Gynecol Cancer 2000; 10: 275-279.

Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C, Tempfer C. Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumor Biol 2000; 21: 309-14.

Obermair A, Petru E, Windbichler G, Peters-Engl C, Graf AH, Stummvoll W, Kaider A, Kurschel S, Klbl H, Sevelda P. Pretreatment serum hemoglobin and survival in early stage epithelial ovarian cancer. Oncol Rep 2000; 7: 639-44.

Obermair A, et al. Does hysteroscopy facilitate tumo rcell dissemination? Incidence of peritoneal cytology in patients with early-stage endometrial cancer following dilatation and curettage (D&C) versus hysteroscopy + D&C. Cancer 2000; 88: 139-143.

Obermair A, et al. Accuracy of the finding of a well differentiated tumor in endometrial cancer patients who undergo a Dilatation & Curettage with subsequent hysterectomy. Int J Gynecol Cancer 1999; 9: 383-386.

Peters-Engl C, Obermair A, Heinzl H, Buxbaum P, Sevelda P, Medl M. CA125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer. Br J Cancer 1999; 81: 662-666.

Jakesz R, Hausmanninger H, Haider K, Kubista E, Samonigg H, Gnant M, Manfreda D, Tschurtschenthaler G, Kolb R, Stierer M, Fridrik M, Mineritsch B, Steindorfer P, Mittelbck M, Steger G, and the Austrian Breast Cancer Study Group. Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer. J Clin Oncol 1999; 17: 1701-1709.

Mayerhofer K, Obermair A, et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999; 74: 196-201

Obermair A, et al. Prediction of toxicity by determining carboplatin exposure in patients with epithelial ovarian cancer treated with a combination of carboplatin and cisplatin. Int J Oncol 1998; 13: 1023-1030.

Obermair A, et al. The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: a prospective review. Cancer 1998; 83: 726-31.

Jakesz R, Samonigg H, Gnant M, Kubista E, Steindorfer P, Hausmanninger H, Sevelda P, Tschurtschenthaler B, Fridrik M, Stierer M, Kolb R, Steger G and the Austrian Breast Cancer Study Group: Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Eur J Cancer 1998; 34:66-70.

Obermair A, et al. Onycholysis in patients treated with docetaxel. Ann Oncol 1998; 9: 230-231 (letter).

Bancher-Todesca D, Obermair A, Zeisler H, Prainsack D, Gitsch G, Reinthaller A. Management unvollstndig entfernter Lsionen nach Schlingenkonisation. Geburtshilfe und Frauenheilkunde 1997; 57: 458-462. [German]

Marth C, Windbichler G, Petru E, Dirschlmayer W, Obermair A, Czerwenka K, Mller-Holzner E, Dapunt O. Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium. Gynecol Oncol 1997; 64: 121-125.

Obermair A, et al. Influence of delayed diagnosis on established prognostic factors in endometrial cancer. Anticancer Ressearch 1996; 16: 947-950.

Obermair A, et al. The influence of obesity on the disease-free survival in primary breast cancer. Anticancer Research 1995; 15: 2265-2270.

Obermair A, et al. Onycholysis in a case of high dose etoposide treatment for ovarian cancer: Gynecol Oncol 1995, 57: 436 (letter).

Sevelda P, Kurz Ch, Obermair A, Kubista E, Salzer H for the Austrian Cooperative Breast Cancer Study Group. Hormontherapie versus Chemo-Hormontherapie bei Patientinnen mit hormonrezeptorpositivem Mammakarzinom im Stadium I und II. Arch Gynecol Obstet 1993; 254: 895-897. [German]

Sevelda P, Mayerhofer K, Obermair A, Stolzlechner J, Kurz Ch. Thrombosis with paclitaxel. Lancet 1994; 343: 727.

Kurz Ch, Obermair A, Schemper M, Kubista E, Sevelda P. Beienflut Adipositas das rezidivfreie Intervall beim Mammakarzinom? Gynkol Geburtshilfliche Rundsch 1993; 33 (Suppl 1): 305-307. [German]

Ch, Salzer H, sterreichische Arbeitsgemeinschaft zur Therapie des Ovarialkarzinoms. Die Bedeutung der Platindosisintensitt in der Behandlung des epithelialen Ovarialkarzinoms. Wien Klin Wochenschr 1993; 105: 732-736. [German]

Sevelda P, Kurz Ch, Obermair A, Vavra N, Breitenecker G, Czerwenka K, Dittrich Ch, Salzer H, Oesterreichische Arbeitsgemeinschaft zur Therapie des Ovarialkarzinoms. Die Bedeutung der Platindosisintensitaet in der Behandlung des epithelialen Ovarialkarzinoma. Wien Klin Wochenschr 1993; 105:732-736 (German)